Marcin Imielinski
Overview
Explore the profile of Marcin Imielinski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
83
Citations
19995
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Li Y, Roberts N, Wala J, Shapira O, Schumacher S, Kumar K, et al.
Nature
. 2023 Jan;
614(7948):E38.
PMID: 36697835
No abstract available.
12.
Gerstung M, Jolly C, Leshchiner I, Dentro S, Gonzalez S, Rosebrock D, et al.
Nature
. 2023 Jan;
614(7948):E42.
PMID: 36697833
No abstract available.
13.
Rheinbay E, Nielsen M, Abascal F, Wala J, Shapira O, Tiao G, et al.
Nature
. 2023 Jan;
614(7948):E40.
PMID: 36697832
No abstract available.
14.
Cyrta J, Rosiene J, Bareja R, Kudman S, Al Zoughbi W, Motanagh S, et al.
Cold Spring Harb Mol Case Stud
. 2022 Dec;
8(7).
PMID: 36577525
Myoepithelial carcinomas (MECs) of soft tissue are rare and aggressive tumors affecting young adults and children, but their molecular landscape has not been comprehensively explored through genome sequencing. Here, we...
15.
Webster A, Sanders M, Patel K, Dietrich R, Noonan R, Lach F, et al.
Nature
. 2022 Nov;
612(7940):495-502.
PMID: 36450981
Fanconi anaemia (FA), a model syndrome of genome instability, is caused by a deficiency in DNA interstrand crosslink repair resulting in chromosome breakage. The FA repair pathway protects against endogenous...
16.
Gajic Z, Deshpande A, Legut M, Imielinski M, Sanjana N
Nat Commun
. 2022 Aug;
13(1):4558.
PMID: 35931739
No abstract available.
17.
Gajic Z, Deshpande A, Legut M, Imielinski M, Sanjana N
Nat Commun
. 2022 Jul;
13(1):3938.
PMID: 35803911
Immune checkpoint blockade (ICB) has transformed the treatment of metastatic cancer but is hindered by variable response rates. A key unmet need is the identification of biomarkers that predict treatment...
18.
Deshpande A, Ulahannan N, Pendleton M, Dai X, Ly L, Behr J, et al.
Nat Biotechnol
. 2022 May;
40(10):1488-1499.
PMID: 35637420
High-order three-dimensional (3D) interactions between more than two genomic loci are common in human chromatin, but their role in gene regulation is unclear. Previous high-order 3D chromatin assays either measure...
19.
Paulson T, Galipeau P, Oman K, Sanchez C, Kuhner M, Smith L, et al.
Nat Commun
. 2022 Apr;
13(1):2300.
PMID: 35484108
While the genomes of normal tissues undergo dynamic changes over time, little is understood about the temporal-spatial dynamics of genomes in premalignant tissues that progress to cancer compared to those...
20.
Leung W, Teater M, Durmaz C, Meydan C, Chivu A, Chadburn A, et al.
Cancer Discov
. 2022 Apr;
12(7):1782-1803.
PMID: 35443279
Significance: Our findings define a B cell-specific oncogenic effect of SETD2 heterozygous mutation, which unleashes AICDA mutagenesis of nontemplate strand DNA in the GC reaction, resulting in lymphomas with heavy...